ALVEOLAR EPITHELIUM-MEDIATED PLASMINOGEN ACTIVATION - CONCOMITANT EXPRESSION OF UROKINASE AND PLASMINOGEN-ACTIVATOR INHIBITOR-1

被引:0
|
作者
GROSS, TJ [1 ]
SIMON, RH [1 ]
KELLY, CJ [1 ]
SITRIN, RG [1 ]
机构
[1] UNIV MICHIGAN,DIV PULM & CRIT CARE MED,ANN ARBOR,MI 48109
来源
CLINICAL RESEARCH | 1990年 / 38卷 / 03期
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:A824 / A824
页数:1
相关论文
共 50 条
  • [31] PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 PREVENTS ACTIVATION OF SINGLE CHAIN UROKINASE TYPE PLASMINOGEN-ACTIVATOR IN PLASMA
    DOSNE, AM
    SAMAMA, M
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1273 - 1273
  • [32] PLASMINOGEN-ACTIVATOR INHIBITOR-1(PAI-1) AND TISSUE-PLASMINOGEN ACTIVATOR PLASMINOGEN-ACTIVATOR INHIBITOR-1(TPA-PAI-1) IN IDDM - PROFILE BY COMPLICATIONS
    SUMINSKI, R
    DASILVA, S
    SMITH, M
    ERBEY, J
    DIABETES, 1994, 43 : A197 - A197
  • [33] Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 and-2 in hepatocellular carcinoma
    Zhou, L
    Hayashi, Y
    Itoh, T
    Wang, WP
    Rui, JA
    Itoh, H
    PATHOLOGY INTERNATIONAL, 2000, 50 (05) : 392 - 397
  • [34] DETERMINANTS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY IN TREATED NIDDM AND ITS RELATION TO A POLYMORPHISM IN THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE
    PANAHLOO, A
    MOHAMEDALI, V
    LANE, A
    GREEN, F
    HUMPHRIES, SE
    YUDKIN, JS
    DIABETES, 1995, 44 (01) : 37 - 42
  • [35] STUDIES OF RECOMBINANT PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN RABBITS - PHARMACOKINETICS AND EVIDENCE FOR REACTIVATION OF LATENT PLASMINOGEN-ACTIVATOR INHIBITOR-1 INVIVO
    VAUGHAN, DE
    DECLERCK, PJ
    VANHOUTTE, E
    DEMOL, M
    COLLEN, D
    CIRCULATION RESEARCH, 1990, 67 (05) : 1281 - 1286
  • [36] UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITOR (PAL-1) EXPRESSION IN COLON DISEASES
    MISELJIC, S
    GALANDIUK, S
    MYERS, SD
    WITTLIFF, JL
    CLINICAL CHEMISTRY, 1995, 41 (06) : S224 - S224
  • [37] REVERSIBLE INTERACTIONS BETWEEN PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITOR-1
    MIMURO, J
    KANEKO, M
    MURAKAMI, T
    MATSUDA, M
    SAKATA, Y
    BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1160 (03) : 325 - 334
  • [38] THE SIGNIFICANCE OF FIBRIN BINDING BY PLASMINOGEN-ACTIVATOR INHIBITOR-1 FOR THE MECHANISM OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR MEDIATED FIBRINOLYSIS
    STRINGER, HAR
    PANNEKOEK, H
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1004 - 1004
  • [39] Plasminogen activator inhibitor-1 partially protects mice against cardiac fibrosis by inhibiting urokinase-type plasminogen activator-mediated plasminogen activation
    Gupta, K. K.
    Donahue, D. L.
    Sandoval-Cooper, M. J.
    Emge, D. J.
    Castellino, F. J.
    Ploplis, V. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 257 - 257
  • [40] Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis
    Lee, Ji-Hye
    Oh, Mee-Hye
    Park, Jae-Seok
    Na, Gyoung-Jae
    Gil, Hye-Wook
    Yang, Jong-Oh
    Lee, Eun-Young
    Hong, Sae-Yong
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2014, 29 (02): : 176 - 182